- 型号:
- 索非布韦片
- 规格:
- 400mg*28片
- 有效期:
- 24个月
Product Name
)Common Name/
)Sofosbuvir Tablets
)
)[Product Price]* Tablets
)
) [Indications] It is a hepatitis C virus nucleotide analog polymerase inhibitor indicated for the treatment of chronic hepatitis C infection as a component of a combination antiviral treatment regimen.
) Efficacy has been established in genotyped or infected subjects, including those with hepatocellular carcinoma meeting Milan criteria (awaiting for liver transplantation) and those with/co-infections.
)
)【Usage and Dosage】
)Take one tablet three times a day with or without food.
) should be used in combination with ribavirin [] or with pegylated interferon [interferon] and ribavirin for treatment. It is recommended that combination therapy
) and ribavirin combined with co-circulatory interferon are not qualified and patients who are not qualified may be considered to be infected by the genotype.
) Patients with hepatocellular carcinoma awaiting liver transplantation until weeks or until liver transplantation should be treated with ribavirin in combination, whichever occurs first.
) Dosage cannot be recommended for patients with severe renal impairment or end-stage renal disease.
)
)【】
) When used in combination with peginterferon/ribavirin or ribavirin alone, the effects of peginterferon and/or ribavirin All contraindications to bavirin also apply to combination therapy.
) Because ribavirin may cause birth defects and fetal death, concomitant use with peginterferon/ribavirin or ribavirin is contraindicated in pregnant women and men and their female partners during pregnancy.
)
) [Precautions] Ribavirin in pregnancy may cause birth defects and fetal death, and animal studies have proven that interferon has an abortive effect. Female patients and the female partners of male patients should avoid pregnancy. Patients must have a negative pregnancy test before starting treatment, use at least one effective non-hormonal method of contraception and have monthly pregnancy tests.
)
) [Adverse Reactions] The most common adverse events (incidence greater than or equal to %, all grades) observed with ribavirin are fatigue and headache. The most common adverse events observed with peginterferon and ribavirin were fatigue, headache, nausea, insomnia, and anemia.
)
)【】piece.
)
)【】Bottled, one tablet
)
)[Manufacturer] Gilead Sciences Inc.